Impel Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IMPEL PHARMS, and what generic alternatives to IMPEL PHARMS drugs are available?
IMPEL PHARMS has one approved drug.
There are six US patents protecting IMPEL PHARMS drugs.
There are sixty-four patent family members on IMPEL PHARMS drugs in sixteen countries.
Summary for Impel Pharms
| International Patents: | 64 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Impel Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impel Pharms | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | 9,550,036 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Impel Pharms | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | 10,507,295 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Impel Pharms | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | 11,185,497 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Impel Pharms | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Impel Pharms | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | 10,940,278 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Impel Pharms | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | 11,266,799 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Impel Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 3111516 | ⤷ Subscribe |
| Japan | 2020185475 | ⤷ Subscribe |
| European Patent Office | 3735244 | ⤷ Subscribe |
| Australia | 2016256665 | ⤷ Subscribe |
| Canada | 2828884 | ⤷ Subscribe |
| Japan | 2021510155 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
